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ABSTRACT 
 
BACKGROUND: According to Braak staging of Parkinson's disease (PD), detection of 
autonomic dysfunction would help with early diagnosis of PD.  
OBJECTIVE: To determine whether the autonomic nervous system is involved in the early 
stage of PD, we evaluated cardiovascular and sudomotor function in early untreated PD 
patients. 
METHODS: Orthostatic blood pressure regulation, heart rate variability, skin vasomotor 
function, and palmar sympathetic sweat responses were examined in 50 early untreated PD 
patients and 20 healthy control subjects.  
RESULTS: The mean decrease in systolic blood pressure during head-up tilt in PD patients 
was mildly but significantly larger than in controls (p = 0.0001). There were no differences 
between the 2 groups in heart rate variability, with analysis of low frequency (LF; mediated by 
baroreflex feedback), and high frequency (HF; mainly reflecting parasympathetic vagal) 
modulation. However, LF/HF, an index of sympatho-parasympathetic balance, was lower in the 
PD group than in controls (p = 0.02). Amplitudes of palmar sweat responses to deep inspiration 
(p = 0.004), mental arithmetic (p = 0.01), and exercise (p = 0.01) in PD patients were lower than 
in controls, with negative correlations with motor severity. Amplitudes of palmar skin 
vasomotor reflexes in PD patients did not differ from controls.  
CONCLUSIONS: Our study indicates impairment of sympathetic cardiovascular and 
sudomotor function with orthostatic dysregulation of blood pressure control, reduced LF/HF 
and reduction in palm sweat responses even in early untreated PD patients. 
 
Key words: Parkinson's disease, autonomic nervous system, cardiovascular system, sudomotor 
function 
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1. Introduction 
Non-motor features of Parkinson's disease (PD) are increasingly being defined, with a 
considerable number attributable to dysfunction of the autonomic nervous system. Autonomic 
abnormalities in PD may result from the disease itself and/or be caused by anti-parkinsonian 
medication. They are known to be more prevalent in advanced PD, but also may occur in early 
stages of the disease[1, 2]. Certain autonomic features, such as constipation, can precede the 
onset of motor symptoms [3]. A proposed six-stage pathological staging of PD suggests a 
predictable sequence of lesions with ascending progression from medullary or olfactory nuclei 
to the cortex. The first two stages are correlated with incidental Lewy body disease, or 
non-motor symptoms, such as hyposmia and constipation [4-6]. Several studies using 123I- 
meta-iodobenzylguanidine (MIBG) scintigraphy indicate that cardiac sympathetic denervation 
occurs in early PD [7] suggesting predominant peripheral cardiovascular autonomic 
involvement. Lewy body pathology may initially occur in the autonomic nervous system [5]. To 
determine whether the autonomic regulation is involved in the early stages of PD, we 
investigated orthostatic blood pressure regulation, heart rate variability and skin vasomotor and 
sudomotor function, as measures of autonomic cardiovascular and sudomotor activity in PD 
patients who had not been treated with anti-Parkinsonian drugs. 
 
2. Subjects and Methods 
2.1 Subjects 
Participants included 50 untreated PD patients (mean age 64.2 ± 8.9 years, 28 men and 22 
women, disease duration 1.8 ± 1.4 years).Modified Hoehn & Yahr stage [8] ranged from 1 to 3 
(mean 1.62 ± 0.69). All met the criteria of the United Kingdom Brain Bank [9]. None were 
taking anti-parkinsonian drugs or any medication that could affect autonomic function. Brain 
MRI scans were performed in all patients, and there were no findings to indicate other 
neurodegenerative disorders, such as multiple system atrophy and ischemic lesions. Twenty 
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age-matched healthy volunteers (mean age, 63.7 ± 7.9 years; 10 men and 10 women) were 
examined as controls. None were taking any medications that could affect autonomic function, 
or had any neurologic disorders or clinically significant illnesses that could affect autonomic 
nervous function, including hypertensive or chronic heart disease. Participants were recruited 
from 2008 to 2010. All patients were under regular follow up (intervals of 4 or 8 weeks) for at 
least 2 years after the study and clinical diagnosis of PD was further confirmed by their 
response to dopaminergic therapy and exclusion of atypical features. All participants were 
recruited in Chiba University Hospital. Informed consent was obtained from all participants. 
The ethics committee of Chiba University School of Medicine approved the protocol and all 
procedures.  
 
2.2 Evaluation of autonomic nervous system function 
Details of autonomic symptoms were obtained in all patients by a neurologist. Cardiovascular, 
sudomotor, bowel and bladder autonomic symptoms were evaluated with a non-validated 
questionnaire in PD patients. Postural symptoms included dizziness, visual disturbance and 
syncope. Urinary symptoms included storage [urinary urgency, daytime urinary frequency (>8 
times /day), nocturia (> once/night) and incontinence] and voiding (urinary hesitancy and 
feeling of incomplete emptying) symptoms. 
 
Autonomic function testing was performed in a quiet room at an ambient temperature of 22–
26C. Each subject was asked to relax, stay awake, and remain in a supine position for at least 
15 min before each test. Before, during and after head-up tilt, blood pressure and heart rate were 
measured by a sphygmomanometer (BP-8800FS; Nihon Colin Co., Tokyo, Japan) at 1-min 
intervals. After 5 min of baseline measurement, each subject was passively tilted on an 
electrically driven tilt table to 70 for 10 min. Orthostatic hypotension was defined as a 
reduction in systolic blood pressure of at least 20 mmHg or diastolic blood pressure of at least 
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10 mmHg within 3 min of tilting [10]. In addition, 'late' orthostatic hypotension was diagnosed 
when blood pressure fell after 3 min of tilting [11]. For evaluating heart rate variability, the 
electrocardiogram was recorded with the subject in a supine position as 300 consecutive R-R 
intervals with an accuracy of 1 ms during normal breathing. As an index of time-domain 
analysis, the coefficient of variation of R-R intervals (CVR-R) was calculated as the standard 
deviation divided by the mean of 100 R-R intervals. The average of 3 series was used as the 
CVR-R value. An abnormal CVR-R value was judged according to age-matched data from our 
laboratory (data not shown). Power spectral analysis of 300 R-R intervals was computed using 
fast Fourier transformation. The power spectrum was quantified into frequency-domain 
measurements; high-frequency oscillations (HF, 0.15–0.4 Hz) and low frequency oscillations 
(LF, 0.04–0.14 Hz) were estimated from the spectra. In addition the ratio between 
low-frequency and high-frequency oscillations (LF/HF) was calculated [12].  
 
As indices of sudomotor and skin vasomotor function, the sympathetic sweat response (SSwR) 
and skin vasomotor reflex (SkVR) were recorded [13, 14]. Sweat output was measured on the 
tip of the thumb (palm side) by a sudorometer (SKD-1000, Skinos, Japan), and cutaneous blood 
flow was measured at the tip of an index finger (palm side) by a Doppler flowmeter (ALF21D, 
Advance, Japan) during sympathetic activation that included deep inspiration, mental arithmetic 
(serial 7 subtraction), and exercise (raising both lower limbs to 30 for 10 s). These procedures 
increase sweat output (SSwR) and reduce cutaneous blood flow (SkVR). The SSwR amplitude 
was measured from the baseline to the peak response, and the SkVR reduction rate was 
calculated as the percentage of the peak reduction in blood flow from basal blood flow 
[(reduced flow/basal flow)  100%].  
 
2.3 Statistical methods 
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Comparisons between 2 groups were analyzed using the Mann-Whitney U test. Spearman 
correlation coefficients were used to examine the relationship between disease duration or 




Clinical features of autonomic dysfunction included postural symptoms (lightheadedness) in 2 
out of 50 PD patients (4%), constipation in 23 (46%), and urinary symptoms (frequency or 
urgency) in 18 (36%). There were no significant differences in baseline blood pressure and heart 
rate while supine between the PD and control groups (Table 1). During head-up tilt, orthostatic 
hypotension occurred in 4 PD patients (8 %), and 'late’ orthostatic hypotension was identified in 
4 PD patients (8 %). These 9 patients were asymptomatic during head-up tilting, but one patient 
with orthostatic hypotension and one with 'late' orthostatic hypotension had a history of 
recurrent lightheadedness according to the questionnaire. The decrease in systolic blood 
pressure during head-up tilt in PD was significantly greater than in controls (p = 0.0001). There 
were no significant differences in the changes in diastolic blood pressure and heart rate between 
the 2 groups (Table 1).  
 
Abnormally low values of CVR-R were observed in 3 PD patients (6 %). The CVR-R values in PD 
patients (2.21 ± 1.37 %) did not significantly differ from that of the controls (2.14 ± 0.89 %). 
There were no significant differences in LF and HF between the PD (128.7 ± 240.1 ms2 and 
122.4 ± 304.0 ms2) and control (117.7 ± 91.0 ms2 and 52.1 ± 49.8 ms2) groups, while the LF/HF 
ratio in the PD group (1.88 ± 1.45) was significantly lower than that in controls (3.4 ± 2.38, p = 
0.01, Fig. 1).  
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There was no significant difference in baseline sweat output between the PD (0.21 ± 0.19 
ml/cm2/min) and controls (0.22 ± 0.11 ml/cm2/min). SSwRs were evoked in all controls, while 3 
PD patients (6%) showed absent SSwR for all of the procedures. SSwR amplitudes in PD 
patients were significantly lower than in controls for deep inspiration (0.17 ± 0.24 ml/cm2/min 
vs. 0.35 ± 0.33 ml/cm2/min, p = 0.007), mental arithmetic (0.23 ± 0.27 ml/cm2/min vs. 0.41 ± 
0.37 ml/cm2/min, p = 0.02), and exercise (0.21 ± 0.23 ml/cm2/min vs. 0.41 ± 0.35 ml/cm2/min, p 
= 0.02, Fig. 2). There was no significant difference in baseline skin blood flow between the 
groups. SkVRs were evoked in all controls and PD patients. The SkVR amplitudes in PD did 
not differ from those in controls (Table 1). Table 2 shows the correlations between the results 
of autonomic function tests and the disease duration or severity. The modified Hoehn & Yahr 
stage was significantly and negatively correlated with the SSwRs for deep inspiration, mental 
arithmetic and exercise (p < 0.05), and the modified Hoehn & Yahr stage tended to be positively 
correlated with the LF/HF ratio (p = 0.05) in the PD group. Age was significantly and 
negatively correlated with changes in diastolic blood pressure during head-up tilting, SSwRs for 
deep inspiration and exercise and CVR-R in the PD group. Age also showed a negative 
correlation with CVR-R in the control group. There were no significant differences in any 
parameters of autonomic tests between male (n = 28) and female (n = 22) patients, between 
patients with (n = 39) and without (n = 11) tremor or between PD patients with (n = 23) and 
without (n = 27) constipation.  
 
4. Discussion 
Post-mortem studies in the premotor phase of PD suggest that Lewy body pathology initially 
appears in anterior olfactory structures, the dorsal motor nucleus of the vagal nerve [4-6], 
paravertebral sympathetic chain [15] and the enteric nervous system [16]. Because cardiac 
parasympathetic nerves arise from the dorsal motor nucleus of the vagal nerve, cardiac 
parasympathetic function may be impaired in the early or premotor phase of PD. However, our 
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study in early PD did not find abnormalities in the HF component, which mainly reflects 
respiratory sinus arrhythmia mediated by parasympathetic vagal nerves. Our results support 
previous studies on the HF component in untreated PD patients, where the HF component was 
preserved [17, 18], except for one study [19], where the HF component was mildly but 
significantly reduced. Early untreated PD patients do not appear to have severe parasympathetic 
cardiac dysfunction. The unchanged HF components suggest that the proposed pathology in the 
dorsal motor nucleus of the vagus nerve was not overtly present in our group of early PD 
patients, and may thus is not consistent with the Braak staging hypothesis. Another possibility is 
that compensatory mechanisms may help maintain cardiovascular autonomic control, despite 
involvement of the dorsal motor nucleus. As an example, vagal control after unilateral 
vagotomy is recovered by peripheral and central compensatory changes in the intact 
contralateral vagus nerve in rabbits [20]. Thus, function observed may not proportionally reflect 
pathological change. Alternatively, analysis of heart rate variability has a low sensitivity for 
detecting cardiac autonomic dysfunction, despite published evidence accepting it in the 
evaluation of autonomic function [21].  
 
In our study, the LF/HF ratio was reduced in untreated PD patients compared to controls. LF is 
mainly produced by baroreflex feedback loops, in which cardiac sympathetic modulation plays 
an important role, and HF mainly reflexes cardiac parasympathetic modulation. Therefore, 
LF/HF is used as an index of sympatho-parasympathetic balance. The reduced LF/HF in our 
untreated PD patients imply a predominant parasympathetic drive to the heart. Accumulation of 
MIBG, which is actively taken up in the sympathetic nerve terminals in the myocardium, is 
reduced even in the early stages of PD [22], and cardiac sympathetic denervation, also using 
tyrosine hydroxylase staining, has been pathologically confirmed in incidental Lewy body 
disease [23]. In addition, LF/HF appeared to show a positive correlation with disease severity 
(modified Hoehn & Yahr stage). Cardiac sympathetic dysfunction may precede parasympathetic 
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dysfunction in PD, and parasympathetic activity may be relatively preserved compared with 
sympathetic activity in the early stages of PD.  
 
Out of our 50 patients, 5 fulfilled the criteria of orthostatic hypotension [10], and an additional 4 
patients showed 'late' orthostatic hypotension [11]. However, no patient complained of postural 
symptoms during head-up tilting. Our results are similar to those in a previous report, where 7 
of 51 untreated PD patients (14%) had a decrease in systolic blood pressure of more than 20 
mmHg on standing and symptoms of hypotension occurred in only 1 patient [24]. The mean 
blood pressure fall during head-up tilt testing in the PD group was statistically significant but 
small. Dysregulation of systemic blood pressure control appears to be mild in the majority of 
early untreated PD patients. Proposed mechanisms of orthostatic blood pressure dysregulation 
in PD include central and peripheral lesions [25]. The sympathetic pathway of blood pressure 
regulation is shown in Fig. 3A. In PD patients, Lewy body pathology is observed in the rostral 
ventrolateral medulla [26-28], which participates in the maintenance of blood pressure [29], and 
also in the intermediolateral nucleus of the thoracic cord [26]. Lewy body deposition has also 
been reported in sympathetic ganglia [15, 26], and cardiac MIBG scintigraphy indicates 
postganglionic sympathetic denervation even in the early stages of PD [22]. Plasma 
noradrenaline concentrations, which reflect postganglionic sympathetic activity, have recently 
been reported to be maintained in the early stages of PD [30], but are unlikely to be a sensitive 
indicator of sympathetic function because of the many processes influencing plasma 
catecholamine levels. In addition, SkVR amplitudes, an index of sympathetic skin 
vasoconstriction function [13, 31, 32], were preserved in our PD patients. These findings 
suggest that functional cardiovascular deficits due to central and peripheral sympathetic lesions 
are evident but of mild severity in the early stages of PD.  
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Previous studies in treated PD patients using the SSwR [13, 33] or sympathetic skin responses 
[34], which is considered to be the electrical reflection of the SSwR [13, 32], report diminished 
palmar sweat responses. Our study confirmed similar results even in early untreated PD patients. 
Sweating on the palm is classified as so-called ‘emotional sweating’. Fig. 3B shows the 
pathway of emotional sweating [35]. The precise central pathway of palmar sweating remains 
unclear with the amygdala, anterior cingulate cortex [36], the reticular formation of the brain 
stem [37] of importance. In addition, the basal ganglia is considered to be important for 
emotional sweating [35]. In our study, SSwR amplitudes showed a negative correlation with 
motor dysfunction severity caused by degeneration of the substantia nigra. Our results support 
previous studies, where sympathetic skin responses were correlated with motor disability in 
treated PD patients [38-40]. Additionally, in our untreated PD patients, sympathetic 
cardiovascular dysfunction was mild compared with sudmotor dysfunction. In a previous study, 
patients with progressive supranuclear palsy, where the substantia nigra is severely affected [41], 
showed diminished SSwR in spite of an intact autonomic nervous system [13]. It is thought that 
the basal ganglia participates in the generation of emotional sweating [35]. Thus, the reduced 
SSwR amplitudes in our PD patients may have reflected dysfunction of the nigrostriatal 
dopamine pathway as well as lesions in the sympathetic nervous system, such as the nucleus 
intermediolateralis and sympathetic ganglia [15, 26], the limbic system, such as the amygdala 
[6], and the reticular formation of the medulla [27].  
 
Our study has revealed impairment of sympathetic cardiovascular and sudomotor function in 
early untreated PD patients. The findings indicate dysregulation of blood pressure control 
during head-up tilt, reduced LF/HF (parasympathetic dominancy of cardiac 
sympatho-sparasympathetic balance) and diminution of the emotional sweat response (SSwR). 
However, sympathetic cardiovascular dysfunction was mild in our early PD patients. 
Cemorouardiovascular autonomic function tests may be insufficient as biomarker tools for early 
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PD detection unlike MIBG scintigraphy. On the other hand, attenuation of SSwR amplitudes 
was prominent in our early PD patients. Furthermore, reductions in SSwR correlated with 
disease severity in our PD patients and may reflect nigral dopaminergic deficiency, as well as 
lesions in the central and peripheral autonomic nervous systems. 
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Figure Legends 
Fig 1.  
Means of the LF (A), HF (B), LF/HF ratios (C) and CVR-R (D) in patients with Parkinson’s 




Mean amplitudes in SSwRs for deep inspiration (A), mental arithmetic (B) and exercise (C) in 
Parkinson’s disease (PD) and control healthy subjects. 
 
Fig. 3. 
Descending sympathetic pathways for regulation of blood pressure (A), heart rate (B) and 
palmar sweating (C).  
Am: amygdala, In: insular cortex, AC: anterior cingulate cortex, HT: hypothalamus, BG: basal 
ganglia, FC: frontal cortex, RVLM: rostral ventrolateral medulla, RVMM: rostral ventromedial 
medulla, IML: intermediolateral nucleus, SG: sympathetic ganglia.  
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Fig. 3 
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